You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia

Showing 51 - 75 of 503
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

Recruiting
  • Waldenstrom's Disease
  • Waldenstrom Macroglobulinemia
  • bone marrow sample
  • blood sample
  • Amiens, France
    CHU Amiens
May 17, 2021

Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

Active, not recruiting
Has Results
  • Waldenström Macroglobulinemia (WM)
  • Acalabrutinib (ACP-196)
  • Santa Barbara, California
  • +37 more
Mar 17, 2022

CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
Feb 24, 2022

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Not yet recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
    • +1 more
    Mar 31, 2021

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

    Terminated
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Apr 22, 2021

    Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia Trial in Australia,

    Recruiting
    • Follicular Lymphoma
    • +7 more
    • Louisville, Kentucky
    • +4 more
    Mar 11, 2022

    Waldenstrom's Macroglobulinemia Trial in Athens, Rotterdam, Salamanca (Bortezomib, Rituximab, Dexamethasone)

    Completed
    • Waldenstrom's Macroglobulinemia
    • Bortezomib, Rituximab, Dexamethasone
    • Athens, Attica, Greece
    • +3 more
    Apr 27, 2021

    Grade 3a Follicular Lymphoma, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in Atlanta, Columbus (other, drug, biological)

    Recruiting
    • Grade 3a Follicular Lymphoma
    • +14 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Atlanta, Georgia
    • +1 more
    May 31, 2022

    B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

    Recruiting
    • B-cell Malignancy, Low-grade
    • +4 more
    • Beijing, Beijing, China
    • +8 more
    Jul 20, 2022

    Waldenstrom's Macroglobulinemia Trial in Denver, Boston (LBH589)

    Completed
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Denver, Colorado
    • +1 more
    Jan 10, 2021

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

    Completed
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +8 more
    • PI3K inhibitor BKM120
    • +3 more
    • Atlanta, Georgia
    • +1 more
    Jun 27, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    Jan 12, 2023

    B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

    Recruiting
    • B-cell Malignancy
    • +8 more
    • Phoenix, Arizona
    • +14 more
    Jan 17, 2023

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

    Active, not recruiting
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +9 more
    • BTK inhibitor PCI-32765
    • +5 more
    • Columbus, Ohio
      Ohio State University Medical Center
    Jun 27, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +23 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 23, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Duarte, California
    • +10 more
    Jul 14, 2022

    Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

    Enrolling by invitation
    • Monoclonal Gammopathy of Undetermined Significance
    • +6 more
      • Milwaukee, Wisconsin
        Aurora Health Care
      Jul 20, 2021

      B-cell Chronic Lymphoid Malignancies Markers

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
        • Strasbourg, France
          Hematology Laboratory - Strasbourg University Hospitals
        Jul 2, 2021

        Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

        Recruiting
        • Relapsed/Refractory B-cell Lymphomas
        • +11 more
        • CLBR001 and SWI019
        • Duarte, California
        • +7 more
        Jul 26, 2022

        MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

        Recruiting
        • Monoclonal Gammopathy of Undetermined Significance (MGUS)
        • +8 more
          • Boston, Massachusetts
          • +6 more
          Apr 14, 2022

          Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

          Recruiting
          • Lymphoma, Non-Hodgkin
          • +9 more
          • NKX019
          • Denver, Colorado
          • +6 more
          Jan 19, 2022

          Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

          Active, not recruiting
          • Adult Grade III Lymphomatoid Granulomatosis
          • +23 more
          • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
          • +2 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

          Active, not recruiting
          • Recurrent B-Cell Non-Hodgkin Lymphoma
          • +22 more
          • Scottsdale, Arizona
          • +1 more
          Aug 10, 2021

          Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

          Recruiting
          • Acute Lymphoblastic Leukemia
          • +16 more
          • Allogeneic Hematopoietic Stem Cell Transplantation
          • +4 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Dec 1, 2022